Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
CVRx, Inc.
CVRX · SEC Filings
website
223
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and br...
Price
0.7806
Market Cap
22.22 M
Float
21.34 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about CVRX
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
CVRx, Inc.
CVRX · SEC Filings
21.34 M
Float
0.7806
Price
22.22 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 5, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 6, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 13, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 6, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 5, 2025
News
TYPE
HEADLINE
FILED AT
8-K
CVRx Reports Third Quarter 2026 Financial and Operating Results and Appoints New CFO
Nov 5, 2026
8-K
CVRx Appoints John Landry as Chief Financial Officer
Sep 21, 2026
8-K
CVRx Announces Sales Leadership Transition
Aug 11, 2026
8-K
CVRx Reports Second Quarter 2026 Financial Results and Updates Full-Year Outlook
Aug 6, 2026
8-K
CVRx Announces Chief Financial Officer Transition
Jun 9, 2026
8-K
CVRx, Inc. Announces Results of 2026 Annual Meeting of Stockholders
Jun 3, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
January 2026 ATM | Offering amount: $50,000,000 | Bank: Jefferies LLC
Jan 12, 2026
424B5
ATM | Offering amount: $50,000,000
Nov 15, 2022
424B4
OFFERING | Shares amount: 7,000,000 | Share price: $18.00 | Offering amount: $126,000,000.00
Jul 1, 2021
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 5, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 13, 2026
S-3
November 2025 SHELF
Nov 6, 2025
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 18, 2025
S-8
Registration
Feb 9, 2024
S-8
Registration
Feb 9, 2024
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 20, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 20, 2026
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 23, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 23, 2025
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 23, 2024
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 23, 2024
Ownerships
TYPE
HEADLINE
FILED AT
SCHEDULE 13D/A
Chernett Jorey (Filed by)
Oct 2, 2026
SCHEDULE 13D
Chernett Jorey (Filed by)
Aug 24, 2026
SCHEDULE 13G
Chernett Jorey (Filed by)
Aug 14, 2026
4
Binkowski Brent (Reporting)
Aug 13, 2026
4
Binkowski Brent (Reporting)
Aug 13, 2026
4
Nielsen Kirk G. (Reporting)
Jun 3, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
SD
Form SD - Specialized disclosure report
May 28, 2026
EFFECT
Form EFFECT - Notice of Effectiveness
Dec 16, 2025
CORRESP
Form CORRESP - Correspondence
Dec 11, 2025
SD
Form SD - Specialized disclosure report
May 23, 2025
SD
Form SD - Specialized disclosure report
May 16, 2024
SD
Form SD - Specialized disclosure report
May 26, 2023
